Starling Oncology (STLNW) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | 24.71% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | -12.23% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -0.46% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | 45.69% |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | 200.06% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 1.48% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 63.93% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -33.85% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | -15.93% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 41.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.10% |
| Mar 31, 2026 | 86.97% |
| Dec 31, 2025 | 40.63% |
| Sep 30, 2025 | -4.14% |
| Jun 30, 2025 | -10.35% |
| Mar 31, 2025 | 19.18% |
| Dec 31, 2024 | 42.27% |
| Sep 30, 2024 | 24.09% |
| Jun 30, 2024 | 24.96% |
| Mar 31, 2024 | 33.70% |
| Dec 31, 2023 | -70.38% |
| Sep 30, 2023 | -551.42% |
| Jun 30, 2023 | -209.87% |
| Mar 31, 2023 | -255.54% |
| Dec 31, 2022 | -10.80% |
| Sep 30, 2022 | -673.67% |
| Jun 30, 2022 | 10.91% |
| Mar 31, 2022 | 238.35% |
| Dec 31, 2021 | -248,350,400.00% |
| Sep 30, 2021 | 82.12% |